Published in Haematologica on July 20, 2007
Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review. Wien Klin Wochenschr (2008) 1.34
BAFF is increased in renal transplant patients following treatment with alemtuzumab. Am J Transplant (2009) 1.06
Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses. Oncoimmunology (2013) 1.01
Treatment and outcomes of immune cytopenias following solid organ transplant in children. Pediatr Blood Cancer (2014) 0.78
Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis. Acta Neuropathol Commun (2016) 0.75
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis (2008) 16.51
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2013) 5.56
Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood (2003) 3.04
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol (2007) 2.70
A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation (2006) 2.55
Comparison of characteristics from White- and Black-Americans with venous thromboembolism: a cross-sectional study. Am J Hematol (2010) 2.26
Mortality assessment for pancreas transplants. Am J Transplant (2004) 2.12
Transplant options for patients undergoing total pancreatectomy for chronic pancreatitis. J Am Coll Surg (2004) 1.98
Sickle cell trait and the risk of venous thromboembolism among blacks. Blood (2007) 1.95
Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood (2004) 1.82
Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation (2008) 1.80
A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients. Clin Infect Dis (2002) 1.77
Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program (2007) 1.65
D-dimer antigen: current concepts and future prospects. Blood (2008) 1.59
Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol (2004) 1.58
Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease. Blood (2014) 1.53
Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry A (2007) 1.48
PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI. Blood (2012) 1.48
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. Thromb Res (2009) 1.43
Follicular hodgkin lymphoma: a histopathologic study. Am J Clin Pathol (2002) 1.43
Major burn injury is not associated with acute traumatic coagulopathy. J Trauma Acute Care Surg (2013) 1.43
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients. Blood (2011) 1.43
Early liver retransplantation in adults. Transpl Int (2013) 1.42
Biliary stricture in living-related donor liver transplantation: management with balloon dilation. Pediatr Transplant (2002) 1.39
Transformed large B-cell lymphoma in rituximab-allergic patient with chronic lymphocytic leukemia after allogeneic stem cell transplant: successful treatment with ofatumumab. Leuk Lymphoma (2012) 1.39
Pancreas after living donor kidney transplants in diabetic patients: impact on long-term kidney graft function. Clin Transplant (2009) 1.31
Vein diameter is the major predictor of fistula maturation. J Vasc Surg (2009) 1.28
Blood coagulation: hemostasis and thrombin regulation. Anesth Analg (2009) 1.24
High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol (2010) 1.23
Outcomes of pancreas transplants for patients with type 2 diabetes mellitus. Clin Transplant (2005) 1.23
Jellyfish as vectors of bacterial disease for farmed salmon (Salmo salar). J Vet Diagn Invest (2010) 1.22
Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematol (2004) 1.21
Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood (2012) 1.20
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment. Am J Hematol (2009) 1.18
Association of coagulation activation with clinical complications in sickle cell disease. PLoS One (2012) 1.17
Technical failures after pancreas transplants: why grafts fail and the risk factors--a multivariate analysis. Transplantation (2004) 1.12
Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure. Hepatology (2013) 1.11
Plasma protein profiling: unique and stable features of individuals. Proteomics (2005) 1.11
Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice. J Clin Invest (2009) 1.11
Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Curr Opin Hematol (2007) 1.08
Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus. Transplantation (2008) 1.08
Hemostatic abnormalities in sickle cell disease. Curr Opin Hematol (2013) 1.08
Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram. Thromb Haemost (2009) 1.07
Effects of caffeine in non-withdrawn volunteers. Hum Psychopharmacol (2005) 1.06
Outcome after pancreatectomy and islet autotransplantation in a pediatric population. J Pediatr Gastroenterol Nutr (2008) 1.06
HLA alloimmunization in patients requiring ventricular assist device support. J Heart Lung Transplant (2002) 1.05
Chronic rejection: the next major challenge for pancreas transplant recipients. Transplantation (2003) 1.05
First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation. Blood (2005) 1.04
Status of blood banking and the blood supply in Afghanistan. Transfusion (2009) 1.04
Microparticles in cardiovascular disease pathophysiology and outcomes. J Am Soc Hypertens (2012) 1.01
The current state of pancreas transplantation. Nat Rev Endocrinol (2013) 0.98
Centrifugation is a crucial step impacting microparticle measurement. Platelets (2009) 0.98
Relationships among musculoskeletal impairments and functional health status in ambulatory cerebral palsy. J Pediatr Orthop (2003) 0.98
Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients. Am J Transplant (2004) 0.97
Cerebrospinal fluid involvement in mantle cell lymphoma. Mod Pathol (2002) 0.97
Effects of repeated doses of caffeine on mood and performance of alert and fatigued volunteers. J Psychopharmacol (2005) 0.97
Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers. Thromb Res (2013) 0.97
Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin. Hepatology (2002) 0.97
Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women. Am J Obstet Gynecol (2009) 0.96
NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis. J Biol Chem (2008) 0.95
Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis. Br J Haematol (2012) 0.95
Measurement of bleeding severity: a critical review. Transfusion (2004) 0.93
Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease. Blood (2012) 0.93
Novel oral anticoagulants: implications in the perioperative setting. Anesthesiology (2010) 0.93
Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survival. Biol Blood Marrow Transplant (2012) 0.93
Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives. Blood (2013) 0.93
Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease. Br J Haematol (2011) 0.92
Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation. Transplantation (2005) 0.91
Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity. Thromb Res (2011) 0.91
Cytokine production by CD4+ T cells specific for coagulation factor VIII in healthy subjects and haemophilia A patients. Thromb Haemost (2007) 0.91
Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations. Clin Cancer Res (2005) 0.90
Analysis of individual platelet-derived microparticles, comparing flow cytometry and capillary electrophoresis with laser-induced fluorescence detection. Analyst (2003) 0.90
Microparticles and cancer. Pathophysiol Haemost Thromb (2009) 0.89
Platelet factor 4 enhances generation of activated protein C in vitro and in vivo. Blood (2003) 0.89
Acquired hemophilia in malignancy. Thromb Res (2012) 0.88
A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease. Thromb Res (2013) 0.88
Circulating levels of tissue factor microparticle procoagulant activity are reduced with antiretroviral therapy and are associated with persistent inflammation and coagulation activation among HIV-positive patients. J Acquir Immune Defic Syndr (2013) 0.87
Postoperative coagulopathy in a pediatric patient after exposure to bovine topical thrombin. Ann Thorac Surg (2007) 0.87
Hematologic changes in sepsis and their therapeutic implications. Semin Respir Crit Care Med (2004) 0.86
Effect of epidural analgesia on postoperative complications following pancreaticoduodenectomy. Am J Surg (2012) 0.86
Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation. Circulation (2003) 0.86
Novel technique of total pancreatectomy before autologous islet transplants in chronic pancreatitis patients. J Am Coll Surg (2011) 0.85
Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease. Br J Haematol (2011) 0.85
A comparison of surgical outcomes and quality of life surveys in right lobe vs. left lateral segment liver donors. Am J Transplant (2005) 0.85
Risk factors and impact of delayed graft function after pancreas transplants. Am J Transplant (2004) 0.85
Blood donor and component management strategies to prevent transfusion-related acute lung injury (TRALI). Crit Care Med (2006) 0.84
Risk factors for rising creatinine in renal allografts with 1 and 3 yr survival. Clin Transplant (2006) 0.84
Lupus anticoagulant associated with transient severe factor X deficiency: a report of two patients presenting with major bleeding complications. Br J Haematol (2003) 0.84
Is prophylaxis required for delivery in women with factor VII deficiency? Haemophilia (2013) 0.84
Activated recombinant factor VII in cardiac surgery. Curr Opin Anaesthesiol (2005) 0.84
Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis. Eur J Cancer (2010) 0.84
Mice with heterozygous deficiency of lipoic acid synthase have an increased sensitivity to lipopolysaccharide-induced tissue injury. J Leukoc Biol (2008) 0.84
Blood utilization in patients with burn injury and association with clinical outcomes (CME). Transfusion (2012) 0.83
Venous thrombosis in blacks. Circulation (2012) 0.83
Long-term outcome in 42 pediatric liver transplant patients with alpha 1-antitrypsin deficiency: a single-center experience. Clin Transplant (2010) 0.83